Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/4794
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKatherine E Eddy, ….. Muttappa R Gudadinni,...WHO ACTION Trial Collaborators.-
dc.date.accessioned2023-04-18T10:59:11Z-
dc.date.available2023-04-18T10:59:11Z-
dc.date.issued2022-
dc.identifier.citationKatherine E Eddy,….. Muttappa R Gudadinni,...WHO ACTION Trial Collaborators. Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial. The Lancet Global Health. 10(10):e1523-e1533, 2022.en_US
dc.identifier.issn2214109X-
dc.identifier.urihttp://hdl.handle.net/123456789/4794-
dc.language.isoenen_US
dc.titleAntenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial.en_US
dc.typeArticleen_US
Appears in Collections:Faculty of Community Medicine

Files in This Item:
File Description SizeFormat 
142_2022.pdf707.04 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.